Heme arginate improves reperfusion patterns after ischemia: A randomized, placebo-controlled trial in healthy male subjects

Journal of Cardiovascular Magnetic Resonance

Volumn 14, Issue 1, 2012, Pages

  Andreas, Martin ^a   Schmid, Albrecht Ingo ^a   Doberer, Daniel ^a   Schewzow, Kiril ^a   Weisshaar, Stefan ^a   Heinze, Georg ^a   Bilban, Martin ^a   Moser, Ewald ^a   Wolzt, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

HEME ARGINATE; PLACEBO;

ADULT; ARTICLE; BOLD SIGNAL; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; CUFF; DOUBLE BLIND PROCEDURE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GASTROCNEMIUS MUSCLE; HUMAN; ISCHEMIC PRECONDITIONING; LEG ISCHEMIA; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION; SINGLE DRUG DOSE; SOLEUS MUSCLE; TIBIALIS ANTERIOR MUSCLE;

ADOLESCENT; ADULT; ARGININE; CROSS-OVER STUDIES; FOLLOW-UP STUDIES; HEME; HEME OXYGENASE (DECYCLIZING); HUMANS; INFUSIONS, INTRAVENOUS; ISCHEMIA; LEG; MAGNETIC RESONANCE IMAGING; MALE; MUSCLE, SKELETAL; OXYGEN CONSUMPTION; PROSPECTIVE STUDIES; REFERENCE VALUES; REPERFUSION INJURY; SINGLE-BLIND METHOD; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84864428068     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-14-55     Document Type: Article

References (35)

1. Progression of myocardial necrosis during reperfusion of ischemic myocardium. Matsumura K, Jeremy RW, Schaper J, Becker LC, Circulation 1998 97 795 804 10.1161/01.CIR.97.8.795 9498544
2. Role of apoptosis in reperfusion injury. Eefting F, Rensing B, Wigman J, Pannekoek WJ, Liu WM, Cramer MJ, Lips DJ, Doevendans PA, Cardiovasc Res 2004 61 414 426 10.1016/j.cardiores.2003.12.023 14962473
3. The role of oxidants and free radicals in reperfusion injury. Zweier JL, Talukder MA, Cardiovasc Res 2006 70 181 190 10.1016/j.cardiores.2006.02.025 16580655
4. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Vinten-Johansen J, Cardiovasc Res 2004 61 481 497 10.1016/j.cardiores.2003.10.011 14962479
5. Postconditioning: reduction of reperfusion-induced injury. Zhao ZQ, Vinten-Johansen J, Cardiovasc Res 2006 70 200 211 10.1016/j.cardiores.2006.01. 024 16545349
6. FFA-induced endothelial dysfunction can be corrected by vitamin C. Pleiner J, Schaller G, Mittermayer F, Bayerle-Eder M, Roden M, Wolzt M, J Clin Endocrinol Metab 2002 87 2913 2917 10.1210/jc.87.6.2913 12050273
7. Effect of systemic vitamin C on free fatty acid-induced lipid peroxidation. Bayerle-Eder M, Pleiner J, Mittermayer F, Schaller G, Roden M, Waldhausl W, Bieglmayer C, Wolzt M, Diabetes Metab 2004 30 433 439 10.1016/S1262-3636(07)70140-4 15671911
8. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Murry CE, Jennings RB, Reimer KA, Circulation 1986 74 1124 1136 10.1161/01.CIR.74.5.1124 3769170
9. Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo. Kharbanda RK, Peters M, Walton B, Kattenhorn M, Mullen M, Klein N, Vallance P, Deanfield J, MacAllister R, Circulation 2001 103 1624 1630 10.1161/01.CIR.103.12.1624 11273988
10. Tolerance to nitroglycerin-induced preconditioning of the endothelium: a human in vivo study. Gori T, Dragoni S, Di Stolfo G, Sicuro S, Liuni A, Luca MC, Thomas G, Oelze M, Daiber A, Parker JD, Am J Physiol Heart Circ Physiol 2010 298 340 H345 10.1152/ajpheart.01324.2008 19933412
11. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Ryter SW, Alam J, Choi AM, Physiol Rev 2006 86 583 650 10.1152/physrev.00011.2005 16601269
12. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Tenhunen R, Marver HS, Schmid R, Proc Natl Acad Sci USA 1968 61 748 755 10.1073/pnas.61.2.748 4386763
13. The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases. Vitek L, Schwertner HA, Adv Clin Chem 2007 43 1 57 17249379
14. TNF-alpha and IL-1alpha induce heme oxygenase-1 via protein kinase C, Ca2+, and phospholipase A2 in endothelial cells. Terry CM, Clikeman JA, Hoidal JR, Callahan KS, Am J Physiol 1999 276 1493 H1501 10330231
15. Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction. Kawamura K, Ishikawa K, Wada Y, Kimura S, Matsumoto H, Kohro T, Itabe H, Kodama T, Maruyama Y, Arterioscler Thromb Vasc Biol 2005 25 155 160 15499042
16. Heme oxygenase-1: unleashing the protective properties of heme. Otterbein LE, Soares MP, Yamashita K, Bach FH, Trends Immunol 2003 24 449 455 10.1016/S1471-4906(03)00181-9 12909459
17. The induction of macrophage hemeoxygenase-1 is protective during acute kidney injury in aging mice. Ferenbach DA, Nkejabega NC, McKay J, Choudhary AK, Vernon MA, Beesley MF, Clay S, Conway BC, Marson LP, Kluth DC, Hughes J, Kidney Int 2011 79 966 976 10.1038/ki.2010.535 21248714
18. Prevention of hemorrhagic shock-induced lung injury by heme arginate treatment in rats. Maeshima K, Takahashi T, Uehara K, Shimizu H, Omori E, Yokoyama M, Tani T, Akagi R, Morita K, Biochem Pharmacol 2005 69 1667 1680 10.1016/j.bcp.2005.03.007 15896346
19. Heme arginate pretreatment attenuates pulmonary NF-kappaB and AP-1 activation induced by hemorrhagic shock via heme oxygenase-1 induction. Sasaki T, Takahashi T, Maeshima K, Shimizu H, Toda Y, Morimatsu H, Takeuchi M, Yokoyama M, Akagi R, Morita K, Med Chem 2006 2 271 274 16948473
20. First-in-human study demonstrating pharmacological activation of heme oxygenase-1 in humans. Bharucha AE, Kulkarni A, Choi KM, Camilleri M, Lempke M, Brunn GJ, Gibbons SJ, Zinsmeister AR, Farrugia G, Clin Pharmacol Ther 2010 87 187 190 10.1038/clpt.2009.221 19956091
21. Haem arginate infusion stimulates haem oxygenase-1 expression in healthy subjects. Doberer D, Haschemi A, Andreas M, Zapf TC, Clive B, Jeitler M, Heinzl H, Wagner O, Wolzt M, Bilban M, Br J Pharmacol 2010 161 1751 1762 10.1111/j.1476-5381.2010.00990.x 20718734
22. Direct noninvasive quantification of lactate and high energy phosphates simultaneously in exercising human skeletal muscle by localized magnetic resonance spectroscopy. Meyerspeer M, Kemp GJ, Mlynarik V, Krssak M, Szendroedi J, Nowotny P, Roden M, Moser E, Magn Reson Med 2007 57 654 660 10.1002/mrm.21188 17390348
23. Dynamic interleaved 1H/31P STEAM MRS at 3 Tesla using a pneumatic force-controlled plantar flexion exercise rig. Meyerspeer M, Krssak M, Kemp GJ, Roden M, Moser E, MAGMA 2005 18 257 262 10.1007/s10334-005-0014-y 16320091
24. Blood oxygenation level-dependent magnetic resonance imaging of the skeletal muscle in patients with peripheral arterial occlusive disease. Ledermann HP, Schulte AC, Heidecker HG, Aschwanden M, Jager KA, Scheffler K, Steinbrich W, Bilecen D, Circulation 2006 113 2929 2935 10.1161/CIRCULATIONAHA. 105.605717 16785340
25. Simultaneous dynamic blood oxygen level-dependent magnetic resonance imaging of foot and calf muscles: aging effects at ischemia and postocclusive hyperemia in healthy volunteers. Kos S, Klarhofer M, Aschwanden M, Scheffler K, Jacob AL, Bilecen D, Invest Radiol 2009 44 741 747 10.1097/RLI.0b013e3181b248f9 19809343
26. Calf muscles at blood oxygen level-dependent MR imaging: aging effects at postocclusive reactive hyperemia. Schulte AC, Aschwanden M, Bilecen D, Radiology 2008 247 482 489 10.1148/radiol.2472070828 18372453
27. Effect of ischemic preconditioning in skeletal muscle measured by functional magnetic resonance imaging and spectroscopy: a randomized crossover trial. Andreas M, Schmid AI, Keilani M, Doberer D, Bartko J, Crevenna R, Moser E, Wolzt M, J Cardiovasc Magn Reson 2011 13 32 10.1186/1532-429X-13-32 21718491
28. Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages. Schmidt HH, Warner TD, Nakane M, Forstermann U, Murad F, Mol Pharmacol 1992 41 615 624 1373797
29. BOLD magnetic resonance imaging of skeletal muscle. Noseworthy MD, Bulte DP, Alfonsi J, Semin Musculoskelet Radiol 2003 7 307 315 14735429
30. Blood oxygen level-dependent MRI of tissue oxygenation: relation to endothelium-dependent and endothelium-independent blood flow changes. Utz W, Jordan J, Niendorf T, Stoffels M, Luft FC, Dietz R, Friedrich MG, Arterioscler Thromb Vasc Biol 2005 25 1408 1413 10.1161/01.ATV.0000170131.13683.d7 15890970
31. Heme oxygenase system in ischemia and reperfusion injury. Tsuchihashi S, Fondevila C, Kupiec-Weglinski JW, Ann Transplant 2004 9 84 87 15478901
32. Different faces of the heme-heme oxygenase system in inflammation. Wagener FA, Volk HD, Willis D, Abraham NG, Soares MP, Adema GJ, Figdor CG, Pharmacol Rev 2003 55 551 571 10.1124/pr.55.3.5 12869663
33. Effect of nitric oxide synthase inhibition on renal hemodynamics in humans: reversal by L-arginine. Wolzt M, Schmetterer L, Ferber W, Artner E, Mensik C, Eichler HG, Krejcy K, Am J Physiol 1997 272 178 F182 9124393
34. How ischaemic preconditioning protects small liver grafts. Franco-Gou R, Rosello-Catafau J, Casillas-Ramirez A, Massip-Salcedo M, Rimola A, Calvo N, Bartrons R, Peralta C, J Pathol 2006 208 62 73 10.1002/path.1859 16261637
35. The obligatory role of COX-2 expression for induction of HO-1 in ischemic preconditioned rat brain. Park MK, Kang YJ, Lee HS, Kim HJ, Seo HG, Lee JH, Chang KC, Biochem Biophys Res Commun 2008 377 1191 1194 10.1016/j.bbrc.2008.10. 149 18992713